{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:13:10Z","timestamp":1789578790366,"version":"build-2803163510"},"reference-count":31,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.3960\/jslrt.17006","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T22:08:56Z","timestamp":1494367736000},"page":"21-25","source":"Crossref","is-referenced-by-count":27,"title":["Stat3 inhibitor abrogates the expression of PD-1 ligands on lymphoma cell lines"],"prefix":"10.3960","volume":"57","author":[{"given":"Chaoya","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasita","family":"Horlad","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Laboratory of Virus Control, Institute for Virus Research, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeju","family":"Lee","sequence":"additional","affiliation":[{"name":"International Research Organization for Advanced Science and Technology (IROAST), Kumamoto University"},{"name":"Magnesium Research Center, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Niidome","sequence":"additional","affiliation":[{"name":"Faculty of Advanced Science and Technology, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuya","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Kyoto Prefectural University of Medicine, Graduate School for Health Care Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Takeya","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Komohara","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Chen L, Han X. Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest 125:3384-3391, 2015"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lussier DM, Johnson JL, Hingorani P, Blattman JN. Combination immunotherapy with \u03b1-CTLA-4 and \u03b1-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma. J Immunother Cancer 3:21, 2015","DOI":"10.1186\/s40425-015-0067-z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Fusi A, Festino L, Botti G, Masucci G, Melero I, Lorigan P, Ascierto PA. PD-L1 expression as a potential predictive biomarker. Lancet Oncol 16:1285-1287, 2015","DOI":"10.1016\/S1470-2045(15)00307-1"},{"key":"4","unstructured":"4 Armand P, Shipp MA, Ribrag V, Michot JM, Zinzani PL, <i>et al<\/i>. Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure. J Clin Oncol. in press"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Eyre TA, Collins GP. Immune checkpoint inhibition in lymphoid disease. Br J Haematol 170:291-304, 2015","DOI":"10.1111\/bjh.13397"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kiyasu J, Miyoshi H, Hirata A, Arakawa F, Ichikawa A, <i>et al<\/i>. Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood 126:2193-2201, 2015","DOI":"10.1182\/blood-2015-02-629600"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, <i>et al<\/i>. PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma. Blood 128:1374-1381, 2016","DOI":"10.1182\/blood-2016-02-698936"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Horlad H, Ma C, Yano H, Pan C, Ohnishi K, <i>et al<\/i>. An IL-27\/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1\/2) on infiltrating macrophages in lymphoma. Cancer Sci 107:1696-1704, 2016","DOI":"10.1111\/cas.13065"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Katoh T, Harada T, Morikawa S, Wakutani T. IL-2- and IL-2-Rindependent proliferation of T-cell lines from adult T-cell leukemia\/lymphoma patients. Int J Cancer 38:265-274, 1986","DOI":"10.1002\/ijc.2910380218"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Lee S, Choi KY, Chung H, Ryu JH, Lee A, <i>et al<\/i>. Real time, high resolution video imaging of apoptosis in single cells with a polymeric nanoprobe. <i>Bioconjug Chem<\/i> 22:125-131, 2011","DOI":"10.1021\/bc1004119"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Lee A, Choi SJ, Park K, Park JW, Kim K, <i>et al<\/i>. Detection of active matrix metalloproteinase-3 in serum and fibroblast-like synoviocytes of collagen-induced arthritis mice. <i>Bioconjug Chem<\/i> 24:1068-1074, 2013","DOI":"10.1021\/bc4001273"},{"key":"12","unstructured":"12 Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 14:736-746, 2014"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Gouilleux-Gruart V, Debierre-Grockiego F, Gouilleux F, Capiod JC, Claisse JFetal. Activated Stat related transcription factors in acute leukemia. Leuk Lymphoma 28:83-88, 1997","DOI":"10.3109\/10428199709058334"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, <i>et al<\/i>. Proliferation of adult T cell leukemia\/lymphoma cells is associated with the constitutive activation of JAK\/STAT proteins. Proc Natl Acad Sci U S A 94:13897-13902, 1997","DOI":"10.1073\/pnas.94.25.13897"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, <i>et al<\/i>. STAT3 is constitutively activated in Hodgkin cell lines. Blood 98:762-770, 2001","DOI":"10.1182\/blood.V98.3.762"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Komohara Y, Horlad H, Ohnishi K, Ohta K, Makino K, <i>et al<\/i>. M2 macrophage\/microglial cells induce activation of Stat3 in primary central nervous system lymphoma. J Clin Exp Hematop 51:93-99, 2011","DOI":"10.3960\/jslrt.51.93"},{"key":"17","unstructured":"17 Nielsen M, Kaltoft K, Nordahl M, R\u00f6pke C, Geisler C, <i>et al<\/i>. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A 94:6764-9, 1997"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Hong D, Kurzrock R, Kim Y, Woessner R, Younes A, <i>et al<\/i>. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci Transl Med 7:314ra185, 2015","DOI":"10.1126\/scitranslmed.aac5272"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Yamamoto R, Nishikori M, Kitawaki T, Sakai T, Hishizawa M, <i>et al<\/i>. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111:3220-3224, 2008","DOI":"10.1182\/blood-2007-05-085159"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Yamamoto R, Nishikori M, Tashima M, Sakai T, Ichinohe T, <i>et al<\/i>. B7-H1 expression is regulated by MEK\/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer Sci 100:2093-100, 2009","DOI":"10.1111\/j.1349-7006.2009.01302.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Marzec M, Zhang Q, Goradia A, Raghunath PN, Liu X, <i>et al<\/i>. Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad Sci U S A 105:20852-20857, 2008","DOI":"10.1073\/pnas.0810958105"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Carbotti G, Barisione G, Airoldi I, Mezzanzanica D, Bagnoli M, <i>et al<\/i>. IL-27 induces the expression of IDO and PD-L1 in human cancer cells. Oncotarget 6:43267-43280, 2015","DOI":"10.18632\/oncotarget.6530"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Ferguson SD, Srinivasan VM, Heimberger AB. The role of STAT3 in tumor-mediated immune suppression. J Neurooncol 123:385-394, 2015","DOI":"10.1007\/s11060-015-1731-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Ueda R, <i>et al<\/i>. The mechanisms of cancer immunoescape and development of overcoming strategies. Int J Hematol 93:294-300, 2011","DOI":"10.1007\/s12185-011-0799-6"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Komohara Y, Jinushi M, Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105:1-8, 2014","DOI":"10.1111\/cas.12314"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, <i>et al<\/i>. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39-49, 1999","DOI":"10.1016\/S1074-7613(00)80005-9"},{"key":"27","unstructured":"27 Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, <i>et al<\/i>. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci 1171:59-76, 2009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Takeya M, Komohara Y. Role of tumor-associated macrophages in human malignancies: friend or foe? Pathol Int 66:491-505, 2016","DOI":"10.1111\/pin.12440"},{"key":"29","unstructured":"29 Bai B, Horlad H, Saito Y, Ohnishi K, Fujiwara Y, <i>et al<\/i>. Role of Stat3 activation in cell-cell interaction between B-cell lymphoma and macrophages: the in vitro study. J Clin Exp Hematop 53:127-33, 2013"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Saito Y, Komohara Y, Niino D, Horlad H, Ohnishi K, <i>et al<\/i>. Role of CD204-positive tumor-associated macrophages in adult T-cell leukemia\/lymphoma. J Clin Exp Hematop 54:59-65, 2014","DOI":"10.3960\/jslrt.54.59"},{"key":"31","unstructured":"31 Sugimoto T, Watanabe T. Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis. J Clin Exp Hematop 56:1-19, 2016"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/57\/1\/57_17006\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T02:47:06Z","timestamp":1569293226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/57\/1\/57_17006\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.17006","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}